Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | PSEN1 | P49768 | 5/20 | 0.43 |
| ▸ | PSEN2 | P49810 | 5/20 | 0.43 |
| ▸ | APH1B | Q8WW43 | 5/20 | 0.43 |
| ▸ | NCSTN | Q92542 | 5/20 | 0.43 |
| ▸ | APH1A | Q96BI3 | 5/20 | 0.43 |
| ▸ | PSENEN | Q9NZ42 | 5/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ACP1 | P24666 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27327204 | 0.90 | CA1 (0.41) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL22600920 | 0.90 | CA1 (0.41) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL24754273 | 0.90 | PSEN1 (0.42) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL12386319 | 0.88 | PSEN1 (0.43) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL111996 | 0.88 | CA1 (0.42) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL24754487 | 0.87 | CA1 (0.44) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL25737834 | 0.86 | FFAR1 (0.42) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL26430427 | 0.85 | FFAR1 (0.41) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL23543589 | 0.85 | CA1 (0.40) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL23709075 | 0.85 | PSEN1 (0.41) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217677-A1 | Organic Electronic Device Comprising a Substrate, an Anode Layer, a Cathode Layer, at Least One First Emission Layer, and a Hole Injection Layer That Comprises a Metal Complex | NOVALED GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| US-11594696-B2 | Organic electronic component and method for producing an organic electronic component | PICTIVA DISPLAYS INTERNATIONAL LIMITED | 2023-02-28 | — | — | US | disclosed |
| US-20230056322-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| WO-2022263494-A1 | AN ORGANIC ELECTRONIC DEVICE COMPRISING A SUBSTRATE, AN ANODE LAYER, A CATHODE LAYER, AT LEAST ONE FIRST EMISSION LAYER, AND AT LEAST ONE HOLE INJECTION LAYER THAT COMPRISES A METAL COMPLEX | NOVALED GMBH (DE) | 2022-12-22 | — | — | WO | disclosed |
| EP-4106026-A1 | AN ORGANIC ELECTRONIC DEVICE COMPRISING A SUBSTRATE, AN ANODE LAYER, A CATHODE LAYER, AT LEAST ONE FIRST EMISSION LAYER, AND AT LEAST ONE HOLE INJECTION LAYER THAT COMPRISES A METAL COMPLEX | Novaled GmbH (DE) | 2022-12-21 | — | — | EP | disclosed |
| WO-2021151959-A1 | AN ORGANIC ELECTRONIC DEVICE COMPRISING AN ANODE LAYER, A CATHODE LAYER, AT LEAST ONE EMISSION LAYER (EML) AND AT LEAST ONE HOLE INJECTION LAYER (HIL) | NOVALED GMBH (DE) | 2021-08-05 | — | — | WO | disclosed |
| US-10910571-B2 | Organic electronic component and use of a fluorinated sulfonimide metal salt | OSRAM OLED GMBH (DE) | 2021-02-02 | — | — | US | disclosed |
| US-20200343468-A1 | ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT | DOLYA HOLDCO 5 LIMITED (IE) | 2020-10-29 | — | — | US | disclosed |
| US-7618683-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2009-11-17 | — | — | US | disclosed |
| US-7618683-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2009-11-17 | — | — | US | disclosed |
| US-20070160815-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2007-07-12 | — | — | US | disclosed |
| US-20070160815-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2007-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230056322-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | AOX1, CYP1B1, CYP1A1 | CA1 1881/4885CA2 3827/4885MMP1 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.